NYSE:ABBV | Market Exclusive

Home Tags NYSE:ABBV

AbbVie Inc (NYSE:ABBV) price target lowered to $115.00 by Argus

ME Staff - November 6, 2018 0

AbbVie Inc (NYSE:ABBV) price target lowered to $71.00 by BMO Capital...

ME Staff - November 5, 2018 0

ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - November 2, 2018 0

AbbVie Inc (NYSE:ABBV) has coverage initiated with a Underperform rating

ME Staff - October 23, 2018 0

AbbVie Inc (NYSE:ABBV) price target lowered to $135.00 by SunTrust Banks

ME Staff - October 22, 2018 0

AbbVie Inc (NYSE:ABBV) price target lowered to $106.00 by Bank of...

ME Staff - October 4, 2018 0

ABBVIE INC. (NYSE:ABBV) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - September 7, 2018 0

AbbVie Inc (NYSE:ABBV) had its Sell rating reiterated by BMO Capital...

ME Staff - August 22, 2018 0

AbbVie Inc (NYSE:ABBV) price target lowered to $105.00 by Bank of...

ME Staff - July 30, 2018 0

ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - July 27, 2018 0

1 234...13 Page 3 of 13

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NYSE:ABBV

AbbVie Inc (NYSE:ABBV) price target lowered to $115.00 by Argus

AbbVie Inc (NYSE:ABBV) price target lowered to $71.00 by BMO Capital...

ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...

AbbVie Inc (NYSE:ABBV) has coverage initiated with a Underperform rating

AbbVie Inc (NYSE:ABBV) price target lowered to $135.00 by SunTrust Banks

AbbVie Inc (NYSE:ABBV) price target lowered to $106.00 by Bank of...

ABBVIE INC. (NYSE:ABBV) Files An 8-K Entry into a Material Definitive...

AbbVie Inc (NYSE:ABBV) had its Sell rating reiterated by BMO Capital...

AbbVie Inc (NYSE:ABBV) price target lowered to $105.00 by Bank of...

ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY